Physician profile
Jason R West
NPI 1629011200
$2,162.94
in general payments reported to CMS, 2019-2025
20 companies · $581 in 2025
The $581 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $174 · 2021: $40.27 · 2022: $124 · 2023: $138 · 2024: $569 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,242 · Education: $45.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.57 |
| Education | $45.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,445.80 | 2020-2025 | Watchman Flx, Farapulse, General - Therapies |
| Pfizer INC. | $124.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $78.13 | 2019-2023 | Xarelto |
| Amgen INC. | $72.36 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.94 | 2019 | |
| Novo Nordisk INC | $55.51 | 2019-2020 | |
| Angiodynamics, INC. | $51.64 | 2024 | Venacure 1470 Pro |
| Mannkind Corporation | $46.26 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $42.66 | 2019 | |
| Merck Sharp & Dohme LLC | $29.83 | 2019 | |
| Exact Sciences Corporation | $20.80 | 2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $20.59 | 2019 | |
| Abbvie INC. | $18.22 | 2020 | |
| Shire North American Group INC | $16.09 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.29 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $15.02 | 2024 | Activase |
| Philips North America LLC | $14.39 | 2020 | |
| Glaxosmithkline, LLC. | $14.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.42 | 2019 | |
| Amarin Pharma, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.